{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:55:15Z","timestamp":1791176115329,"version":"4.1.0"},"reference-count":20,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1080\/00365540110026593","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T15:21:26Z","timestamp":1027696886000},"page":"545-549","source":"Crossref","is-referenced-by-count":23,"title":["Immunogenicity and Reactogenicity of a New Measles, Mumps and Rubella Vaccine When Administered as a Second Dose at 12 y of Age"],"prefix":"10.1080","volume":"33","author":[{"family":"Leif Gothefors, Erik Bergstr\u00f6m, Mar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","first-page":"1264","volume":"295","author":"B\u00f6ttiger M","year":"1987","journal-title":"Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps and rubella. BMJ"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/bmj.287.6389.389","volume":"287","author":"Christensson B","year":"1983","journal-title":"BMJ"},{"key":"CIT0003","first-page":"77","volume":"169","author":"Briss P-A","year":"1994","journal-title":"al. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Inf Dis"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2105\/AJPH.79.4.475","volume":"79","author":"Mathias RC","year":"1989","journal-title":"Am J Publ Health"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2105\/AJPH.81.3.360","volume":"81","author":"Hersh BS","year":"1991","journal-title":"Am J Publ Health"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM198703263161303","volume":"316","author":"Gustafson TL","year":"1987","journal-title":"N Engl J Med"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/rmv.1980050406","volume":"5","author":"Balraj V","year":"1995","journal-title":"Rev Med Virol"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0140-6736(93)91069-X","volume":"341","author":"Miller E","year":"1993","journal-title":"Lancet"},{"key":"CIT0009","first-page":"42","volume":"18","author":"Usonis V","year":"1999","journal-title":"Reactogenicity and immunogenicity of a novel live attenuated combined measles, mumps and rubella vaccine in healthy children. Pediatr Inf Dis J"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF02962367","volume":"26","author":"Usonis V","year":"1998","journal-title":"Infection"},{"key":"CIT0011","first-page":"511","volume":"30","author":"Gatchalian S","year":"1999","journal-title":"Southeast Asian J Trop Med Publ Health"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0264-410X(00)00081-5","volume":"18","author":"Crovari P","year":"2000","journal-title":"Vaccine"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199411243312101","volume":"331","author":"Peltola H","year":"1994","journal-title":"N Engl J Med"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","volume":"162","author":"Chen RT","year":"1990","journal-title":"J Infect Dis"},{"key":"CIT0015","first-page":"170","volume":"106","author":"Samb B","year":"1996","journal-title":"Pediatr Infect Dis J 1995; 14: 203\u20139.16. Skendzel LP. Rubella immunity: defining the level of protective antibody. Am J Clin Pathol"},{"key":"CIT0016","first-page":"252","volume":"276","author":"Hilleman MR","year":"1967","journal-title":"Live attenuated mumps-virus vaccine. N Engl J Med"},{"key":"CIT0017","first-page":"260","volume":"165","author":"Weibel RE","year":"1980","journal-title":"Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps and rubella virus vaccines 40967. Proc Soc Exp Biol Med"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/archpedi.1962.02080020384038","volume":"103","author":"Hilleman MR","year":"1962","journal-title":"Am J Dis Child"},{"key":"CIT0019","first-page":"269","volume":"16","author":"Berger R","year":"1988","journal-title":"Gluck R. Interference between strains in live virus vaccines. I: combined vaccination with measles, mumps and rubella vaccine. J Biol Stand"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1442-200X.1996.tb03471.x","volume":"38","author":"Kimura M","year":"1996","journal-title":"Acta Paediatr Jpn"}],"container-title":["Scandinavian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00365540110026593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T06:39:13Z","timestamp":1497508753000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00365540110026593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1080\/00365540110026593"],"URL":"https:\/\/doi.org\/10.1080\/00365540110026593","relation":{},"ISSN":["0036-5548","1651-1980"],"issn-type":[{"value":"0036-5548","type":"print"},{"value":"1651-1980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}